Dr. Sidarth Dasari
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- Indiana University School of Medicine (2017)
- Years since graduation
- 9
- In the NPI registry since
- 2017
- Medicare patients seen, 2024
- 251
Licensed in Vermont since 2021, according to the Vermont Board of Medical Practice. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2017Medical school: Indiana University School of Medicine
- 2017Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
CO license DR.0068451 (first issued 2022; active) · NY license 311231 · VT license 042-0015282 (first issued 2021; lapsed)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Poudre Valley Hospital Fort Collins, CO
- Medical Center of the Rockies Loveland, CO
- Longs Peak Hospital Longmont, CO
- Boulder Community Health Boulder, CO
- Ivinson Memorial Hospital Laramie, WY
Medical groups
- Select Physical Therapy of West Denver Limited PArtnership (548 clinicians)
- Advanced Neurology of Colorado LLC (7 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 251
- Services billed
- 6,031
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 162 | 119 |
| Established patient office or other outpatient visit, 40-54 minutes | 150 | 109 |
| New patient office or other outpatient visit, 60-74 minutes | 118 | 118 |
| New patient office or other outpatient visit, 45-59 minutes | 61 | 61 |
| Established patient office or other outpatient visit, 20-29 minutes | 48 | 37 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Boulder, CO | 89 |
| Donepezil Hcl Other prescribers in Boulder, CO | 65 |
| Baclofen Other prescribers in Boulder, CO | 41 |
| Levetiracetam Other prescribers in Boulder, CO | 39 |
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Boulder, CO | 36 |
| Amantadine (amantadine hcl) Other prescribers in Boulder, CO | 26 |
| Pregabalin Other prescribers in Boulder, CO | 24 |
| Duloxetine Hcl Other prescribers in Boulder, CO | 24 |
| Lamotrigine Other prescribers in Boulder, CO | 21 |
| Qulipta (atogepant) Other prescribers in Boulder, CO | 21 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 39 companies reported 313 payments worth $38,684 in total to this clinician.
| Tg Therapeutics, Inc. | $27,831 |
|---|---|
| EMD Serono, Inc. | $3,988 |
| Pfizer Inc. | $1,678 |
| AbbVie Inc. | $845 |
| Biogen, Inc. | $677 |
| Novartis Pharmaceuticals Corporation | $517 |
| Genzyme Corporation | $410 |
| Lundbeck LLC | $339 |
| Compensation for services other than consulting (speaking, faculty) | $23,230 |
|---|---|
| Food and Beverage | $8,600 |
| Consulting Fee | $4,675 |
| Travel and Lodging | $2,178 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Tg Therapeutics, Inc. Oct 27, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,673 |
| Tg Therapeutics, Inc. Jun 2, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,673 |
| Tg Therapeutics, Inc. Apr 24, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,108 |
| Tg Therapeutics, Inc. Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,108 |
| Tg Therapeutics, Inc. May 19, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,108 |
| Tg Therapeutics, Inc. Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,108 |
| EMD Serono, Inc. Oct 17, 2025 | Consulting Fee Mavenclad · Neurology Company’s descriptionAdvisory Board Participation (Fee For Service) | $3,000 |
| Pfizer Inc. Oct 2, 2025 | Consulting Fee NURTEC ODT · PAIN | $1,525 |
| Tg Therapeutics, Inc. May 6, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $1,163 |
| Tg Therapeutics, Inc. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $1,130 |
All 22 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Tg Therapeutics, Inc. Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $465 |
| Tg Therapeutics, Inc. Oct 27, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,673 |
| Tg Therapeutics, Inc. Oct 27, 2025 | Travel and Lodging BRIUMVI · Immunology · travel to Colorado Springs, CO · in-kind | $1,113 |
| EMD Serono, Inc. Oct 17, 2025 | Consulting Fee Mavenclad · Neurology Company’s descriptionAdvisory Board Participation (Fee For Service) | $3,000 |
| Pfizer Inc. Oct 2, 2025 | Consulting Fee NURTEC ODT · PAIN | $1,525 |
| Tg Therapeutics, Inc. Sep 11, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $233 |
| Tg Therapeutics, Inc. Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,108 |
| Tg Therapeutics, Inc. Aug 20, 2025 | Travel and Lodging BRIUMVI · Immunology · travel to Greenwood Village, CO | $104 |
| Tg Therapeutics, Inc. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $1,130 |
| Tg Therapeutics, Inc. Jun 2, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,673 |
| Tg Therapeutics, Inc. Jun 2, 2025 | Travel and Lodging BRIUMVI · Immunology · travel to Durango, CO | $299 |
| Tg Therapeutics, Inc. Jun 2, 2025 | Travel and Lodging BRIUMVI · Immunology · travel to Durango, CO · in-kind | $279 |
| Tg Therapeutics, Inc. Jun 2, 2025 | Travel and Lodging BRIUMVI · Immunology · travel to Durango, CO | $254 |
| Biogen, Inc. May 28, 2025 | Consulting Fee TYSABRI · Neurology | $150 |
| Tg Therapeutics, Inc. May 19, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,108 |
| Tg Therapeutics, Inc. May 19, 2025 | Travel and Lodging BRIUMVI · Immunology · travel to Lone Tree, CO | $71.40 |
| Tg Therapeutics, Inc. May 6, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $1,163 |
| Tg Therapeutics, Inc. Apr 24, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,108 |
| Tg Therapeutics, Inc. Apr 24, 2025 | Travel and Lodging BRIUMVI · Immunology · travel to Fort Collins, CO | $40.60 |
| Tg Therapeutics, Inc. Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,108 |
| Tg Therapeutics, Inc. Apr 14, 2025 | Travel and Lodging BRIUMVI · Immunology · travel to Colorado Springs, CO | $17.50 |
| Tg Therapeutics, Inc. Mar 17, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $465 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 3 companies. The companies reported $264,898 in research payments for these studies, mostly to the institutions running them.
- (ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study
Tg Therapeutics, Inc. - A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment …
Novartis Pharmaceuticals Corporation - Ocrelizumab RMS High Dose Study
Genentech, Inc. - Ocrelizumab PPMS High Dose Study
Genentech, Inc. - Evaluation of Fenebrutinib in RMS patients
Genentech, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.